Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review Article

Mohyuddin, Ghulam Rehman, Aziz, Muhammad, Britt, Alec et al. (2020). Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review . BMC CANCER, 20(1), 10.1186/s12885-020-06948-5

Open Access

cited authors

  • Mohyuddin, Ghulam Rehman; Aziz, Muhammad; Britt, Alec; Wade, Lee; Sun, Weijing; Baranda, Joaquina; Al-Rajabi, Raed; Saeed, Anwaar; Kasi, Anup

sustainable development goals

authors

publication date

  • June 3, 2020

published in

keywords

  • BRCA
  • BREAST-CANCER
  • Germline
  • Life Sciences & Biomedicine
  • MAINTENANCE THERAPY
  • Meta-analysis
  • OLAPARIB
  • OVARIAN
  • Oncology
  • PARP inhibitors
  • RUCAPARIB
  • Science & Technology
  • Somatic

Digital Object Identifier (DOI)

publisher

  • BMC

volume

  • 20

issue

  • 1